In Episode 2 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Jose L. Merino, MD, PhD to explore what it means to truly personalize antiarrhythmic drug (AAD) therapy across diverse patient populations. Together, they discuss real-world strategies for tailoring treatment based on age, comorbidities, arrhythmia type, and individual risk factors — highlighting how precision medicine is reshaping rhythm management. From dosing considerations to emerging research and clinical challenges, viewers will gain actionable insight to help optimize AAD use in varied care settings and deliver more confident, patient-centered treatment.
Stay tuned for Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home
Additional Resources
https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true
https://www.jacc.org/doi/10.1016/j.jacep.2024.11.020
Listen on:
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
Resource Type
- HRStv Podcast
Related Resources
HRStv Podcast
Episode 162: Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmias – #HRS2026 LBCT
April 27, 2026
HRStv Podcast
Episode 161: #HRS2026 Day 4 Wrap Up
April 27, 2026
HRStv Podcast
Episode 160: #HRS2026 Day 3 Wrap Up
April 27, 2026